Literature DB >> 32632751

Vascular KATP channels protect from cardiac dysfunction and preserve cardiac metabolism during endotoxemia.

Qadeer Aziz1, Jianmin Chen1, Amie J Moyes1, Yiwen Li1, Naomi A Anderson1, Richard Ang1, Dunja Aksentijevic2, Sonia Sebastian1, Adrian J Hobbs1, Christoph Thiemermann1, Andrew Tinker3.   

Abstract

KATP channels in the vasculature composed of Kir6.1 regulate vascular tone and may contribute to the pathogenesis of endotoxemia. We used mice with cell-specific deletion of Kir6.1 in smooth muscle (smKO) and endothelium (eKO) to investigate this question. We found that smKO mice had a significant survival disadvantage compared with their littermate controls when treated with a sub-lethal dose of lipopolysaccharide (LPS). All cohorts of mice became hypotensive following bacterial LPS administration; however, mean arterial pressure in WT mice recovered to normal levels, whereas smKO struggled to overcome LPS-induced hypotension. In vivo and ex vivo investigations revealed pronounced cardiac dysfunction in LPS-treated smKO, but not in eKO mice. Similar results were observed in a cecal slurry injection model. Metabolomic profiling of hearts revealed significantly reduced levels of metabolites involved in redox/energetics, TCA cycle, lipid/fatty acid and amino acid metabolism. Vascular smooth muscle-localised KATP channels have a critical role in the response to systemic infection by normalising cardiac function and haemodynamics through metabolic homeostasis. KEY MESSAGES: • Mice lacking vascular KATP channels are more susceptible to death from infection. • Absence of smooth muscle KATP channels depresses cardiac function during infection. • Cardiac dysfunction is accompanied by profound changes in cellular metabolites. • Findings from this study suggest a protective role for vascular KATP channels in response to systemic infection.

Entities:  

Keywords:  Cardiac metabolism; Endotoxemia; KATP; Kir6.1; Vascular smooth muscle

Year:  2020        PMID: 32632751      PMCID: PMC7399691          DOI: 10.1007/s00109-020-01946-3

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  41 in total

Review 1.  Regulation of myocardial oxygen delivery.

Authors:  B Schremmer; J F Dhainaut
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Inhibition of c-Jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction.

Authors:  Konstantinos Drosatos; Zoi Drosatos-Tampakaki; Raffay Khan; Shunichi Homma; P Christian Schulze; Vassilis I Zannis; Ira J Goldberg
Journal:  J Biol Chem       Date:  2011-08-26       Impact factor: 5.157

3.  Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock.

Authors:  J F Dhainaut; M F Huyghebaert; J F Monsallier; G Lefevre; J Dall'Ava-Santucci; F Brunet; D Villemant; A Carli; D Raichvarg
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

4.  Cardiac contractility and structure are not significantly compromised even during the late, hypodynamic stage of sepsis.

Authors:  M Zhou; P Wang; I H Chaudry
Journal:  Shock       Date:  1998-05       Impact factor: 3.454

Review 5.  Protein and amino acid metabolism in human muscle.

Authors:  A J Wagenmakers
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

6.  Abnormal activation of potassium channels in aortic smooth muscle of rats with peritonitis-induced septic shock.

Authors:  Jiunn-Horng Kuo; Shiu-Jen Chen; Chih-Chin Shih; Wei-Ming Lue; Chin-Chen Wu
Journal:  Shock       Date:  2009-07       Impact factor: 3.454

Review 7.  The role of mitochondria in sepsis-induced cardiomyopathy.

Authors:  Giacomo Stanzani; Michael R Duchen; Mervyn Singer
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-10-17       Impact factor: 5.187

Review 8.  Metabolism, Metabolomics, and Nutritional Support of Patients with Sepsis.

Authors:  Joshua A Englert; Angela J Rogers
Journal:  Clin Chest Med       Date:  2016-03-12       Impact factor: 2.878

9.  Hypotension due to Kir6.1 gain-of-function in vascular smooth muscle.

Authors:  Anlong Li; Russell H Knutsen; Haixia Zhang; Patrick Osei-Owusu; Alex Moreno-Dominguez; Theresa M Harter; Keita Uchida; Maria S Remedi; Hans H Dietrich; Carlos Bernal-Mizrachi; Kendall J Blumer; Robert P Mecham; Joseph C Koster; Colin G Nichols
Journal:  J Am Heart Assoc       Date:  2013-08-23       Impact factor: 5.501

10.  The ATP-sensitive potassium channel subunit, Kir6.1, in vascular smooth muscle plays a major role in blood pressure control.

Authors:  Qadeer Aziz; Alison M Thomas; John Gomes; Richard Ang; William R Sones; Yiwen Li; Keat-Eng Ng; Lorna Gee; Andrew Tinker
Journal:  Hypertension       Date:  2014-06-09       Impact factor: 10.190

View more
  2 in total

Review 1.  Kir6.1 and SUR2B in Cantú syndrome.

Authors:  Conor McClenaghan; Colin G Nichols
Journal:  Am J Physiol Cell Physiol       Date:  2022-07-25       Impact factor: 5.282

Review 2.  Functional Regulation of KATP Channels and Mutant Insight Into Clinical Therapeutic Strategies in Cardiovascular Diseases.

Authors:  Zhicheng Wang; Weikang Bian; Yufeng Yan; Dai-Min Zhang
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.